Home » SpectrumX Holdings » SpectrumX Pre-IPO Raise

SpectrumX Pre-IPO Raise

This Pre-IPO offering outlines the opportunities for the commercialisation of novel formulations of HOCL in the healthcare and pharmaceutical markets. Specifically how the SpectrumX Group can positively impact these sectors, through a diversified portfolio of offerings, by exploiting licenses from Spectrum Antimicrobials Inc., of the world’s first and only patent-protectable formulations of HOCL (Hypochlorous Acid).

The company is focused on bringing to market a groundbreaking respiratory therapy (SPC-069) and the roll out of the most powerful hand sanitiser in the world (Spectricept™). Both products utilise unique patent pending HOCL formulations.

HOCL is naturally occurring in human’s white blood cells and is a key contributor to mankind’s evolution and protection over millions of years. It is human safe whilst also being the most effective disinfectant known to mankind.


Leave a comment

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.